DBD
DBD
NYSE · Technology

Diebold Nixdorf Inc

$78.14
+1.30 (+1.69%)
Financial Highlights (FY 2026)
Revenue
2.83B
Net Income
70.25M
Gross Margin
26.4%
Profit Margin
2.5%
Rev Growth
+3.2%
D/E Ratio
0.86
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 26.4% 26.4% 62.0% 62.0%
Operating Margin 6.4% 5.7% 23.8% 24.5%
Profit Margin 2.5% 2.4% 21.9% 24.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.83B 2.74B 350.37M 397.27M
Gross Profit 745.22M 721.97M 217.38M 246.48M
Operating Income 179.73M 156.71M 83.22M 97.46M
Net Income 70.25M 61.25M 76.72M 98.58M
Gross Margin 26.4% 26.4% 62.0% 62.0%
Operating Margin 6.4% 5.7% 23.8% 24.5%
Profit Margin 2.5% 2.4% 21.9% 24.8%
Rev Growth +3.2% +3.2% +6.5% +14.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 570.04M 570.04M 538.36M 459.72M
Total Equity 663.77M 663.77M 1.05B 1.01B
D/E Ratio 0.86 0.86 0.51 0.46
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 274.38M 252.53M 102.75M 125.92M
Free Cash Flow 87.64M 93.06M